repeat expansion disorders therapeutics
/ Triplet Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 26, 2020
Triplet Therapeutics to present at Cowen 40th Annual Health Care Conference
(Businesswire)
- “Triplet Therapeutics, Inc…will present at the Cowen and Company 40th Annual Health Care Conference taking place in Boston March 2-4, 2020…will provide an overview of Triplet’s approach and recent progress to develop transformative treatments for repeat expansion disorders, a group of more than 40 known genetic diseases including...myotonic dystrophy. Triplet is developing antisense oligonucleotide (ASO) and small interfering RNA (siRNA) therapeutics to precisely modulate the DDR mechanism that drives repeat expansion and has the potential to address repeat expansion disorders...”
Preclinical
1 to 1
Of
1
Go to page
1